The role of axonal pathology in MS disability

It is well recognized that in end-stage multiple sclerosis (MS) pathology there is axon loss. Since the axons of central nervous system fibre tracts regenerate very poorly (if at all), it is axon loss that is likely to be responsible for the permanent clinical deficits of MS. Thus, the key question...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Perry, V, Woolley, S, Anthony, D
Fformat: Journal article
Iaith:English
Cyhoeddwyd: 1999
_version_ 1826281547030855680
author Perry, V
Woolley, S
Anthony, D
author_facet Perry, V
Woolley, S
Anthony, D
author_sort Perry, V
collection OXFORD
description It is well recognized that in end-stage multiple sclerosis (MS) pathology there is axon loss. Since the axons of central nervous system fibre tracts regenerate very poorly (if at all), it is axon loss that is likely to be responsible for the permanent clinical deficits of MS. Thus, the key question is not whether there is axon degeneration in MS, but when it occurs during the course of the disease. If it develops early in the disease, and is not just a consequence of long-standing demyelination, this would suggest that therapies directed at preventing the pathology early in the disease should be implemented. This article reviews the recent evidence that axonal damage does indeed occur early in MS and considers the mechanisms by which an inflammatory response might damage the axons acutely.
first_indexed 2024-03-07T00:30:26Z
format Journal article
id oxford-uuid:7f98bf78-00f6-4e98-a9da-042f5f43e8cd
institution University of Oxford
language English
last_indexed 2024-03-07T00:30:26Z
publishDate 1999
record_format dspace
spelling oxford-uuid:7f98bf78-00f6-4e98-a9da-042f5f43e8cd2022-03-26T21:17:54ZThe role of axonal pathology in MS disabilityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7f98bf78-00f6-4e98-a9da-042f5f43e8cdEnglishSymplectic Elements at Oxford1999Perry, VWoolley, SAnthony, DIt is well recognized that in end-stage multiple sclerosis (MS) pathology there is axon loss. Since the axons of central nervous system fibre tracts regenerate very poorly (if at all), it is axon loss that is likely to be responsible for the permanent clinical deficits of MS. Thus, the key question is not whether there is axon degeneration in MS, but when it occurs during the course of the disease. If it develops early in the disease, and is not just a consequence of long-standing demyelination, this would suggest that therapies directed at preventing the pathology early in the disease should be implemented. This article reviews the recent evidence that axonal damage does indeed occur early in MS and considers the mechanisms by which an inflammatory response might damage the axons acutely.
spellingShingle Perry, V
Woolley, S
Anthony, D
The role of axonal pathology in MS disability
title The role of axonal pathology in MS disability
title_full The role of axonal pathology in MS disability
title_fullStr The role of axonal pathology in MS disability
title_full_unstemmed The role of axonal pathology in MS disability
title_short The role of axonal pathology in MS disability
title_sort role of axonal pathology in ms disability
work_keys_str_mv AT perryv theroleofaxonalpathologyinmsdisability
AT woolleys theroleofaxonalpathologyinmsdisability
AT anthonyd theroleofaxonalpathologyinmsdisability
AT perryv roleofaxonalpathologyinmsdisability
AT woolleys roleofaxonalpathologyinmsdisability
AT anthonyd roleofaxonalpathologyinmsdisability